Cargando…

Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)

BACKGROUND: Lenvatinib inhibits tyrosine kinases, including vascular endothelial growth factor (VEGF) receptor, fibroblast growth factor receptor, platelet-derived growth factor receptor alpha, RET proto-oncogene and KIT proto-oncogene, receptor tyrosine kinase. We assessed the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwasa, Satoru, Okita, Natsuko, Kuchiba, Aya, Ogawa, Gakuto, Kawasaki, Mamiko, Nakamura, Kenichi, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Boku, Narikazu, Yamada, Yasuhide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440718/ https://www.ncbi.nlm.nih.gov/pubmed/32817132 http://dx.doi.org/10.1136/esmoopen-2020-000776

Ejemplares similares

Esophageal Metastasis from Rectal Cancer Successfully Treated with Fluorouracil-Based Chemotherapy with Bevacizumab: A Case Report and Review of the Literature
por: Watanabe, Sho, et al.
Publicado: (2017)

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer
por: Oshima, Kotoe, et al.
Publicado: (2022)

Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy
por: Tada, Kohei, et al.
Publicado: (2015)

Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy
por: Tamura, Nobumasa, et al.
Publicado: (2020)

Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer
por: Takamizawa, Shigemasa, et al.
Publicado: (2021)

Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection
por: Shoji, Hirokazu, et al.
Publicado: (2014)

Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies
por: Takahashi, Naoki, et al.
Publicado: (2016)

Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer
por: Aoki, Masahiko, et al.
Publicado: (2019)

Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab
por: Kadono, Toru, et al.
Publicado: (2023)

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811)
por: Shoji, Hirokazu, et al.
Publicado: (2021)

Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer
por: Takahashi, Naoki, et al.
Publicado: (2015)

Tumor growth rate during re-challenge chemotherapy with previously used agents as salvage treatment for metastatic colorectal cancer: A retrospective study
por: Ishikawa, Masashi, et al.
Publicado: (2021)

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab
por: Masuda, Ken, et al.
Publicado: (2019)

Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
por: Takahashi, Naoki, et al.
Publicado: (2015)

Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy for unresectable sinonasal undifferentiated carcinoma: Two cases of report
por: Watanabe, Sho, et al.
Publicado: (2019)

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
por: Honma, Yoshitaka, et al.
Publicado: (2019)

Relationship between cervical esophageal squamous cell carcinoma and human papilloma virus infection and gene mutations
por: Fukahori, Masaru, et al.
Publicado: (2021)

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
por: Takahashi, Naoki, et al.
Publicado: (2014)

The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
por: Shoji, Hirokazu, et al.
Publicado: (2017)

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma
por: Hayashi, Hidetoshi, et al.
Publicado: (2014)

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
por: Nishikawa, Tadaaki, et al.
Publicado: (2023)

P1503: ETIOPATHOGENESIS OF CANCER-RELATED ANEMIA AMONG CHILDREN AND ADOLESCENTS WITH MALIGNANT SOLID TUMORS
por: Kader, Salwa Mostafa Abd El Kader, et al.
Publicado: (2023)

Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer
por: Imaizumi, Jun, et al.
Publicado: (2023)

Prognostic factors of brain metastases from colorectal cancer
por: Imaizumi, Jun, et al.
Publicado: (2019)

One Electron Changes Everything: Synthesis, Characterization, and Reactivity Studies of [Re(NCCH(3))(6)](3+)
por: Bolliger, Robin, et al.
Publicado: (2022)

1503 Individual Accountability and Direct Feedback to Achieve and Sustain Good Hand Hygiene Performance
por: Maragakis, Lisa L., et al.
Publicado: (2014)

Severe Falciparum and Vivax Malaria on the Thailand-Myanmar Border: A Review of 1503 Cases
por: Chu, Cindy S, et al.
Publicado: (2023)

Comparison of model fit and discriminatory ability of M category as defined by the 7th and 8th editions of the tumor‐node‐metastasis classification of colorectal cancer and the 9th edition of the Japanese classification
por: Shida, Dai, et al.
Publicado: (2021)

A multi-institutional observational study evaluating the incidence and the clinicopathological characteristics of NeoRAS wild-type metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2023)

1503. No Benefit to Treating Male UTI for Longer Than 7 Days: An Outpatient Database Study
por: Germanos, George, et al.
Publicado: (2018)

Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan
por: Shida, Dai, et al.
Publicado: (2018)

Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer
por: Takamizawa, Yasuyuki, et al.
Publicado: (2020)

Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study
por: Kitadai, Rui, et al.
Publicado: (2021)

Medición de la resistencia de aislamiento a máquinas eléctricas utilizando megger modelo 1503 /
por: Marín Solís, José Heriberto
Publicado: (2011)

Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
por: Kudo-Saito, Chie, et al.
Publicado: (2022)

HER2-positive gastric cancer
por: Boku, Narikazu
Publicado: (2013)

1503. Risk Factors for Contracting Infection with SARS-CoV-2: a Prospective Case-control Study
por: Shoar, Saeed, et al.
Publicado: (2020)

Bitter lemons
por: Durrell, Lawrence
Publicado: (1996)

A multi-centre, double-blind, randomized, placebo-controlled trial to evaluate the effectiveness and safety of ramelteon for the prevention of postoperative delirium in elderly cancer patients: a study protocol for JORTC-PON2/J-SUPPORT2103/NCCH2103
por: Sadahiro, Ryoichi, et al.
Publicado: (2023)

OA15.03. Cost savings associated with mindfulness meditation and moderate exercise intervention in the common cold (The MEPARI Study)
por: Rakel, D, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_92b8jmb6t0pnjdrlmi90m9ko6m